Gamida Cell Ltd. GMDA
0.03 +0.03
Day range unavailable
52-week range unavailable
News
businesswire.com Gamida Cell Presents Positive Initial Results on Treating Severe Aplastic Anemia (SAA) with Omidubicel LONDON--(BUSINESS WIRE)--Ayrmid Ltd. (“Ayrmid” or the “Company”), the parent company of Gamida Cell Inc., a cell therapy pioneer working to turn cells into powerful therapeutics, announced positive…
globenewswire.com On Path to First-in-Human Study, NurExone Engages Prominent Expert in Biological Drug Development TORONTO and HAIFA, Israel, June 21, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company,…
businesswire.com Gamida Cell Announces New Leadership Under Ownership of Highbridge Capital Management BOSTON--(BUSINESS WIRE)--Gamida Cell (the “Company”), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced new executive leadership following a successful…
benzinga.com Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly…
benzinga.com Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of…
benzinga.com Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket Shares of RH (NYSE: RH) rose sharply in today’s pre-market trading following the release of quarterly results.
investorplace.com Why Is Gamida Cell (GMDA) Stock Down 82% Today? Gamida Cell (NASDAQ: GMDA ) stock is falling hard on Wednesday after the clinical-stage biopharmaceutical company announced major changes to its business in its Q4 earnings report. This big news here…
seekingalpha.com Gamida Cell Ltd. (GMDA) Q4 2023 Earnings Call Transcript Gamida Cell Ltd. (GMDA) Q4 2023 Earnings Call Transcript
globenewswire.com Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update Company announces commencement of restructuring process supported by Highbridge Capital Management Continued progress of launch of Omisirge ® (omidubicel-onlv), with the delivery of six units in…
globenewswire.com Gamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital Management Company expected to receive significant new capital from Highbridge to bolster the commercialization of allogeneic stem cell transplant Omisirge ® (omidubicel-onlv)
benzinga.com Earnings Scheduled For March 27, 2024 Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million.
globenewswire.com Gamida Cell to Report Fourth Quarter and Full-Year 2023 Financial Results BOSTON, March 22, 2024 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that the company will release its…
globenewswire.com Gamida Cell Data Presented at the 2024 Tandem Meetings of ASTCT® and CIBMTR® Expanded access program (EAP) data for omidubicel are consistent with Phase 3 trial results on rates of hematopoietic recovery and infections following stem cell transplant with Omisirge ®…
globenewswire.com Gamida Cell Actively Pursuing Strategic Alternatives BOSTON, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced it is actively pursuing strategic…
globenewswire.com Gamida Cell to Present at the 2024 Tandem Meetings of ASTCT® and CIBMTR® BOSTON, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced it will present new data on its FDA…
globenewswire.com Gamida Cell to Host Virtual Thought Leader Fireside Chat on December 4, 2023 BOSTON, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, is hosting a virtual fireside chat with thought…
globenewswire.com Gamida Cell to Present Corporate Highlights at the Piper Sandler 35th Annual Healthcare Conference BOSTON, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that its management team will…- benzinga.com Small-Caps Grossly Underperform Broader Market Amid This Red Flag: 5 Stocks On The Scanner Small-cap stocks have not taken off significantly this year despite the broader market rebound, primarily due to their increasing debt burden, a report says.
benzinga.com Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results.
seekingalpha.com Gamida Cell Ltd. (GMDA) Q3 2023 Earnings Call Transcript Gamida Cell Ltd. (NASDAQ:GMDA ) Q3 2023 Earnings Conference Call November 14, 2023 8:30 AM ET Company Participants Mike Kuczkowski - Corporate Communications Abbey Jenkins - President & Chief…
benzinga.com Earnings Scheduled For November 14, 2023 Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue of $18.00 million.
globenewswire.com Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company Update Company continues to advance launch, reports initial revenue from Omisirge ® (omidubicel-onlv)
globenewswire.com Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual Meeting Data further characterize the mechanism for Gamida Cell's proprietary nicotinamide (NAM) technology's expansion and enhancement of cells Data further characterize the mechanism for Gamida Cell's…
globenewswire.com Gamida Cell to Report Third Quarter 2023 Financial Results BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that the company will release its…
businesswire.com Gamida Cell Reports Preliminary Data from Phase 1 Study of Natural Killer (NK) Cell Therapy Candidate GDA-201 BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced new early data in 10 patients with CD20 positive…
businesswire.com Gamida Cell Issues Update on Israel Operations BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today issued an update on its operations in Israel. “We remain…
marketwatch.com These Israeli pharmaceutical stocks are down in the wake of Hamas attack Shares of Israeli pharmaceutical companies took a hit in premarket trades Monday after Hamas' attack on Israel.
benzinga.com Earnings Scheduled For August 14, 2023 Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.- benzinga.com Earnings Scheduled For May 15, 2023 Companies Reporting Before The Bell • Caledonia Mining (AMEX:CMCL) is expected to report earnings for its first quarter. • Sohu.com (NASDAQ:SOHU) is projected to report earnings for its first quarter.
- benzinga.com Why MIND Technology Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket Gainers
benzinga.com Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering.- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 89 stocks made new 52-week lows.
benzinga.com Earnings Scheduled For March 27, 2023 Companies Reporting Before The Bell • Viomi Technology Co (NASDAQ:VIOT) is likely to report earnings for its fourth quarter. • Vislink Technologies (NASDAQ:VISL) is projected to report earnings for…
benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 297 companies reached new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Monday Monday saw 196 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 127 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday During Thursday's trading, 138 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday Wednesday saw 219 companies set new 52-week lows.
- benzinga.com Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday Gainers Cosmos Holdings Inc. (NASDAQ: COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on…
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday's trading, 160 companies set new 52-week lows.
- benzinga.com Earnings Scheduled For November 14, 2022 Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday Wednesday's session saw 361 companies set new 52-week lows.
- benzinga.com Earnings Scheduled For August 15, 2022 Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.
- benzinga.com Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 120 companies achieved new lows for the year.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 100 companies reached new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday During Friday's session, 61 companies made new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 588 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday During Monday's trading, 1214 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 422 stocks made new 52-week lows.